BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Crucial Data Solutions Release: A More Modern ResearchKit Alternative For Study Developers

  Crucial Data Solutions offers fully-featured app for EDC in clinical trials, an ideal alternative to Apple’s ResearchKit framework.

  December 19, 2017

   · 

  5 min read
• Sartorius Stedim Biotech Launches New Versions of Data Analytics Software Solutions

  SIMCA and SIMCA-online software updates in the Umetrics Suite help manufacturing industries make better business decisions and optimize process control

  December 19, 2017

   · 

  3 min read
• Policy

  Samsung Bioepis’ SB3 Trastuzumab Biosimilar Candidate Accepted for Review by the US Food and Drug Administration

  Samsung Bioepis today announced that the FDA has accepted for review the company’s Biologics License Application (BLA) under the 351(k) pathway for SB3, a biosimilar candidate referencing Herceptin (trastuzumab).

  December 19, 2017

   · 

  1 min read